Expert Review of Cardiovascular Therapy

Rationale for aggressive lipid lowering: evidence from clinical trials
pp. 305-309(5)
Author: Farmer, John A

News in Brief
pp. 311-313(3)

Eplerenone in the treatment of chronic heart failure
pp. 315-320(6)
Authors: Krum, Henry; Liew, Danny

Clinical application of enoxaparin
pp. 321-337(17)
Author: Hofmann, Thomas

Lepirudin: a bivalent direct thrombin inhibitor for anticoagulation therapy
pp. 339-357(19)
Author: Greinacher, Andreas

New European, American and International guidelines for hypertension management: agreement and disagreement
pp. 359-368(10)
Authors: Stergiou, George S; Salgami, Eleanna V

Hypertension and left ventricular hypertrophy in autosomal dominant polycystic kidney disease
pp. 369-374(6)
Authors: Ecder, Tevfik; Schrier, Robert W

Prognostic value of ambulatory blood pressure measurements for the diagnosis of hypertension in pregnancy
pp. 375-391(17)
Authors: Hermida, Ramón C; Ayala, Diana E

Pharmacology of orthostatic hypotension in Parkinson’s disease: from pathophysiology to management
pp. 393-403(11)
Authors: Pathak, Atul; Senard, Jean-Michel

Hypolipidemic treatment of heterozygous familial hypercholesterolemia: a lifelong challenge
pp. 405-415(11)
Authors: Vuorio, Alpo F; Kovanen, Petri T; Gylling, Helena

High-density lipoproteins: multifunctional vanguards of the cardiovascular system
pp. 417-430(14)
Authors: Marcil, Michel; O'Connell, Brian; Krimbou, Larbi; Genest Jr, Jacques

Achieving lipid goals in Europe: how large is the treatment gap?
pp. 431-449(19)
Authors: Schwandt, Peter; Brady, Adrian JB